Alpine Global Management’s iShares Biotechnology ETF IBB Stock Holding History

Alpine Global Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-12,816	Closed	-$1.76M	–	492
2024 Q1	$1.76M	Buy	+12,816	New	+$1.75M	0.34%	67
2023 Q3	–	Sell	-3,960	Closed	-$503K	–	188
2023 Q2	$503K	Buy	+3,960	New	+$514K	0.14%	92
2022 Q2	–	Sell	-2,411	Closed	-$314	–	576
2022 Q1	$314	Sell	2,411 -79,879	-97%	-$10.4M	0.07%	159
2021 Q4	$12.6M	Buy	+82,290	New	+$12.7M	1.85%	4
2021 Q3	–	Sell	-2,115	Closed	-$346K	–	323
2021 Q2	$346K	Buy	+2,115	New	+$326K	0.05%	167
2020 Q1	–	Sell	-2,563	Closed	-$309K	–	330
2019 Q4	$309K	Buy	+2,563	New	+$286K	0.07%	268
2019 Q3	–	Sell	-3,804	Closed	-$415K	–	91
2019 Q2	$415K	Buy	+3,804	New	+$405K	0.12%	44
2018 Q4	–	Sell	-6,525	Closed	-$796K	–	246
2018 Q3	$796K	Buy	+6,525	New	+$768K	0.15%	44
2016 Q2	–	Sell	-2,970	Closed	-$258K	–	223
2016 Q1	$258K	Buy	+2,970	New	+$266K	0.06%	102
2014 Q2	–	Sell	-42,471	Closed	-$3.35M	–	200
2014 Q1	$3.35M	Buy	+42,471	New	+$3.54M	2.88%	5

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Alpine Global Management's IBB Position: Q2 2024 in Review

Alpine Global Management sold out of iShares Biotechnology ETF (IBB) in Q2 2024, closing a stake of 12,816 shares — an estimated $1.76M sold.

Alpine Global Management first reported a position in IBB in Q1 2014 and held it in 10 quarters. The position peaked at $12.6M in Q4 2021. 894 funds tracked by Wall St. Rank hold IBB as of Q2 2024.

Alpine Global Management reported no remaining iShares Biotechnology ETF position as of Q2 2024 after selling out during the quarter.
Alpine Global Management sold 12,816 iShares Biotechnology ETF shares in Q2 2024, an estimated $1.76M.
Alpine Global Management first reported a position in iShares Biotechnology ETF in Q1 2014 and held it in 10 quarters.
Alpine Global Management's iShares Biotechnology ETF position peaked at $12.6M in Q4 2021.
894 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2024.

Based on Alpine Global Management's 13F filing for Q2 2024, filed 14 Aug 2024.